Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multi-institution evaluation of deformable image registration algorithms for automatic organ delineation in adaptive head and neck radiotherapy.
Hardcastle N, Tomé WA, Cannon DM, Brouwer CL, Wittendorp PW, Dogan N, Guckenberger M, Allaire S, Mallya Y, Kumar P, Oechsner M, Richter A, Song S, Myers M, Polat B, Bzdusek K. Hardcastle N, et al. Radiat Oncol. 2012 Jun 15;7:90. doi: 10.1186/1748-717X-7-90. Radiat Oncol. 2012. PMID: 22704464 Free PMC article.
Long-Term Outcomes of TROG 13.01 SAFRON II Randomized Trial of Single- Versus Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases.
Siva S, Sakyanun P, Mai T, Wong W, Lim A, Ludbrook J, Bettington C, Rezo A, Pryor D, Hardcastle N, Kron T, Higgs B, Le H, Skala M, Gill S, Eade T, Awad R, Sasso G, Vinod S, Montgomery R, Ball D, Bressel M. Siva S, et al. Among authors: hardcastle n. J Clin Oncol. 2023 Jul 1;41(19):3493-3498. doi: 10.1200/JCO.23.00150. Epub 2023 May 14. J Clin Oncol. 2023. PMID: 37179526 Clinical Trial.
The dosimetric error due to uncorrected tumor rotation during real-time adaptive prostate stereotactic body radiation therapy.
Sengupta C, Skouboe S, Ravkilde T, Poulsen PR, Nguyen DT, Greer PB, Moodie T, Hardcastle N, Hayden AJ, Turner S, Siva S, Tai KH, Martin J, Booth JT, O'Brien R, Keall PJ. Sengupta C, et al. Among authors: hardcastle n. Med Phys. 2023 Jan;50(1):20-29. doi: 10.1002/mp.16094. Epub 2022 Nov 28. Med Phys. 2023. PMID: 36354288 Free PMC article.
NeoAdjuvant pembrolizumab and STEreotactic radiotherapy prior to nephrectomy for renal cell carcinoma (NAPSTER): A phase II randomised clinical trial.
Ali M, Wood S, Pryor D, Moon D, Bressel M, Azad AA, Mitchell C, Murphy D, Zargar H, Hardcastle N, Kearsley J, Eapen R, Wong LM, Cuff K, Lawrentschuk N, Neeson PJ, Siva S. Ali M, et al. Among authors: hardcastle n. Contemp Clin Trials Commun. 2023 Apr 22;33:101145. doi: 10.1016/j.conctc.2023.101145. eCollection 2023 Jun. Contemp Clin Trials Commun. 2023. PMID: 37168818 Free PMC article.
Recommendation on the technical and dosimetric data to be included in stereotactic body radiation therapy clinical trial publications based on a systematic review.
Hardcastle N, Josipovic M, Clementel E, Hernandez V, Smyth G, Gober M, Wilke L, Eaton D, Josset S, Lazarakis S, Saez J, Vieillevigne L, Jornet N, Mancosu P. Hardcastle N, et al. Radiother Oncol. 2024 Jan;190:110042. doi: 10.1016/j.radonc.2023.110042. Epub 2023 Dec 1. Radiother Oncol. 2024. PMID: 38043902 Review.
Applicability and usage of dose mapping/accumulation in radiotherapy.
Murr M, Brock KK, Fusella M, Hardcastle N, Hussein M, Jameson MG, Wahlstedt I, Yuen J, McClelland JR, Vasquez Osorio E. Murr M, et al. Among authors: hardcastle n. Radiother Oncol. 2023 May;182:109527. doi: 10.1016/j.radonc.2023.109527. Epub 2023 Feb 10. Radiother Oncol. 2023. PMID: 36773825 Free article. Review.
193 results